Anemia: Rationale Approach to Diagnosis and Treatment |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
What’s on the Pipeline? A Look into Clinical Research for the APP |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
|
Enduring |
|
$0.00 |
Navigating the Terrain: Insights into the Current Landscape, Treatment Strategies, and a Clinical Trial of Triple Negative Breast Cancer |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
|
Enduring |
|
$0.00 |
Oral Oncoloytic Therapy: How to Optimize Your Patients' Care |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Updates in Management of Advanced Renal Cell Carcinoma: Making Sense of the Menu |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Genetic Testing and Counseling in the Community Setting: Germline and Somatic |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Revolutionizing Leukemia Treatment: Allogeneic Transplants, Engineered T Cell Therapy, and Navigating the Complexities of GVHD |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Gynecologic Oncology: Pelvic Mass and Abnormal Bleeding |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Hitting the Target: Updates and Review in Genotype Directed Therapy for Non-Small Cell Lung Cancer |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Treating Cancer with Bispecific Antibodies: Current Status and Future Directions |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
|
Enduring |
|
$0.00 |
Updates in Lymphoma 2024 |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Shame in Medicine: Changing the Culture of Medicine |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
|
Enduring |
|
$0.00 |
Neuroendocrine Neoplasms: Not All Hoofbeats Are Horses |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
|
Enduring |
|
$0.00 |
Thrombotic Microangiopathies: Deeper Dive Into Effective Management Strategies |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Expanding the Role of Immunotherapy: New Regimens for Use in the Adjuvant and Neoadjuvant Settings |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |